Reelin anticorps (AA 1796-2115)
Aperçu rapide pour Reelin anticorps (AA 1796-2115) (ABIN7871363)
Antigène
Voir toutes Reelin (RELN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 1796-2115
-
Fonction
- Reelin Antibody / RELN
-
Purification
- Protein A/G affinity
-
Immunogène
- A portion of amino acids 1796-2115 was used as the immunogen for the Reelin antibody.
-
Isotype
- IgG2b
-
-
-
-
Indications d'application
- Optimal dilution of the Reelin antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the Reelin antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- Reelin (RELN)
-
Autre désignation
- Reelin
-
Sujet
- Reelin (or Reln) is a large glycoprotein that is secreted by Cajal-Retzius cells in the forebrain and by granule neurons in the cerebellum. Reelin was shown to be mutated in reeler mice, a mutation that is associated with widespread disruption of laminated regions of the brain, leading to impaired motor coordination, tremors and ataxia. Reelin protein expression is complex and changes throughout development. Reelin appears to function upstream of Dab1, in a signaling pathway that controls cell positioning in the developing brain, and is also thought to be a direct effector of the neurotrophin BDNF.
-
UniProt
- P78509
-
Pathways
- Synaptic Membrane
Antigène
-